Startup profile · funding coverage
Happy Health funding, valuation and investors
FDA-cleared smart ring and physician-guided platform for at-home sleep apnea diagnosis and continuous home care.
Keep track of Happy Health
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Series A (reported) / cumulative $75M (BI caveat)
$75M · August 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
$75M
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
series a · Austin, Texas
Investors in latest funding
Lead: ARCH Venture Partners , OpenLoop
Overview
Happy Health builds the Happy Ring and Happy Sleep platform for at-home multi-night sleep testing and physician-guided sleep care, with ambitions to expand continuous home monitoring beyond obstructive sleep apnea. Mid-August 2026 coverage reported $75 million from ARCH Venture Partners and OpenLoop. Fierce Healthcare and Dealroom describe a Series A; Business Insider describes $75 million across rounds since 2019 with the last tranche in 2025. The ring has FDA clearances cited for biometrics (2024) and at-home sleep testing (June 2025).
Why Happy Health is interesting
Mid-August 2026 $75M financing announcement from ARCH Venture Partners and OpenLoop for clinical-grade Happy Ring sleep care — with conflicting reports on whether $75M is new Series A capital or cumulative since 2019.
Product & use cases
Clinical smart ring plus AI analysis and physician network for home sleep diagnosis and management.
- At-home multi-night OSA diagnosis
- Ongoing sleep care with in-network physicians
- Future continuous monitoring for chronic disease (roadmap)
Key facts
- $75M financing announced mid-Aug 2026 from ARCH and OpenLoop (Fierce/MedCity) — verify new vs cumulative (BI caveat)
- FDA-cleared Happy Ring for at-home multi-night sleep testing (company/press)
- In-network claims include Blue Cross and Medicare (company)
Funding history (newest first)
Series A (reported) / cumulative $75M (BI caveat)
2026-08 $75M- ARCH Venture Partners (lead)
- OpenLoop (lead)
Source: https://www.fiercehealthcare.com/finance/happy-health-secures-75m-ai-driven-home-based-care-platform
Investors in our directory
Funds linked from Happy Health's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Regulated ring pathway plus care delivery — not only consumer biometrics.
Happy Health’s scoreboard is clearance, payer coverage, and diagnosed-treated funnel — not ring units sold as lifestyle. Reconcile $75M new-vs-cumulative reporting before modeling runway.
-
Oura / Whoop adjacent
Consumer wellness rings.
-
Traditional home sleep tests / labs incumbent
Clinical standard; less convenient multi-night form factor.
-
Other FDA wearables direct
Fragmented clinical wearable market.
Notable stories
- Founder Dustin Freckleton cites personal stroke and delayed OSA diagnosis as the origin of Happy Health’s home-first thesis (Fierce Healthcare, Aug 2026).
Industries
Market / IPO context
Editorial / static context — not a live quote.
Related funding articles
Venture Capital Tracker pieces that cover Happy Health's financing or category context.
FAQs about Happy Health
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.